Osaic Holdings’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Osaic Holdings’s Portfolio QNTM Stock Details QNTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.8K	Buy	6,375 +1,105	+21%	+$4.98K	﹤0.01%	5560
2025 Q4	$38.5K	Buy	5,270 +4,590	+675%	+$50.1K	﹤0.01%	5415
2025 Q3	$11.4K	Buy	680 +600	+750%	+$11.8K	﹤0.01%	6285
2025 Q2	$1.62K	Buy	+80	New	+$986	﹤0.01%	7006
2025 Q1	–	Sell	-15	Closed	-$55	–	7761
2024 Q4	$55	Hold	15	–	–	﹤0.01%	7284
2024 Q3	$58	Hold	15	–	–	﹤0.01%	7289
2024 Q2	$160	Hold	15	–	–	﹤0.01%	7195
2024 Q1	$710	Hold	15	–	–	﹤0.01%	6753
2023 Q4	$919	Hold	15	–	–	﹤0.01%	6781
2023 Q3	$1.21K	Hold	15	–	–	﹤0.01%	6775
2023 Q2	$1.15K	Hold	15	–	–	﹤0.01%	6840
2023 Q1	$1.55K	Hold	15	–	–	﹤0.01%	6811
2022 Q4	$1K	Hold	15	–	–	﹤0.01%	6995
2022 Q3	$1K	Hold	15	–	–	﹤0.01%	7102
2022 Q2	$1K	Hold	15	–	–	﹤0.01%	7181
2022 Q1	$1K	Hold	15	–	–	﹤0.01%	7137
2021 Q4	$1K	Hold	15	–	–	﹤0.01%	7268
2021 Q3	$2K	Hold	15	–	–	﹤0.01%	6899
2021 Q2	$2K	Buy	+15	New	+$1.74K	﹤0.01%	6764

Other funds holding QNTM

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

PTP

Platform Technology Partners New York $611M AUM 25.5% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Marex Group London $15.8B AUM 31.44% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SPIA

Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return

AUB

Atlantic Union Bankshares Glen Allen, Virginia $5.21B AUM 19.46% 1-Year Est. Return

Osaic Holdings's QNTM Position: Q1 2026 in Review

Osaic Holdings increased its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) stake by 21% in Q1 2026, buying an estimated $4.98K and bringing the position to 6,375 shares worth $30.8K. The position accounts for ﹤0.01% of the portfolio, ranked #5560.

Osaic Holdings first reported a position in QNTM in Q2 2021 and has held it in 19 quarters since. The position peaked at $38.5K in Q4 2025. 25 funds tracked by Wall St. Rank hold QNTM as of Q1 2026.

Osaic Holdings held 6,375 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $30.8K as of Q1 2026.
Osaic Holdings bought 1,105 Quantum Biopharma Class B Subordinate Voting Shares shares in Q1 2026, an estimated $4.98K.
Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5560 holding.
Osaic Holdings first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q2 2021 and has held it in 19 quarters since.
Osaic Holdings's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $38.5K in Q4 2025.
25 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.